Aminoglycoside market Opportunities, Growth and Forecast Report 2025

Posted by rekha on September 9th, 2019

Precision Business Insights (PBI) in its report titled “Global Aminoglycoside market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2024” assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global aminoglycosides market was valued at US$ XX Mn in 2018 and increasing at a significant CAGR over the forecast timeframe owing to surge in the incidence of bacterial diseases such as tuberculosis, increasing number of manufacturing companies, factors such as resistance developed by the bacteria for blockbuster drugs, presence of characteristics such as bactericidal, concentration-dependent killing action, and activity against staphylococci, certain mycobacteria in humans and against E. coli, Proteus, Pseudomonas, Salmonella, Shigella, Serratia, and Enterobacter in animals are expected to drive the global aminoglycosides market. However,adverse effects associated with the use of aminoglycosides such as irreversible hearing loss, muscle twitching, and seizure are anticipated to hinder the revenue share of global aminoglycosides market.

Global aminoglycosides market segmented on the basis of drug, mode of administration, application, distribution channel and Geography.

For request sample:

Respiratory Applications Dominates the Global Aminoglycoside market

Based on applications, global aminoglycosides market segmented intoveterinary, skin, respiratory, UTI & pelvic disease, neonatal sepsis. Among them respiratory applications dominated the global aminoglycosides market in 2018 and estimated to dominate over the forecast period, owing to the high prevalence of respiratory diseases such as tuberculosis in developing regions across the globe and effective treatment of the aminoglycosides towards the respiratory diseases. However, an increased growth rate observed in case of veterinary segment due to increasing number of pets surge the market over the forecast years.

Asia Pacific Leads the Global Aminoglycoside market


PBI’s global aminoglycosides market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, Asia Pacific accounted for larger revenue share through 2014-2018 and expected to dominate over 2019-2025 owing to the high prevalence rate of bacterial diseases, high incidence of multidrug resistant tuberculosis, presence of major suppliers of aminoglycosides in the region, advanced healthcare systems and the incidence of bacterial diseases are anticipated to propel the market. North America aminoglycosides market projected to exhibit significant growth due to entry of major generic market players and increase in research and development, increasing demand, increasing opportunities for market growth boost the market.



Launch of newer formulation products, frequent product approvals, and strategic alliances are the key strategies adopted by market players


Global aminoglycosides market further reveals that the key players increasingly adopting strategies such as launch of newer technologies of needle free injector products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. In 2018, Achaogen, Inc., a biopharmaceutical company, developed and commercialized ZEMDRI, an innovative antibacterial agent to address multi-drug resistant (MDR) gram-negative infections.

Key player’s profiles in the report are

  • Kremoint Pharma Pvt. Ltd (India)
  • Hangzhou Uniwise International Co., Ltd (China)
  • HuvePharma (Bulgaria)
  • Achaogen Inc (US)
  • SelectX Pharmaceuticals, Inc (US)
  • Vega Pharma Ltd. (China)
  • Yichang Sanxia Pharmaceutical Co., Ltd. (China)
  • Jiangxi Bolai Pharmacy Co., Ltd (China)
  • Alfasan International BV (Netherlands)
  • Medico Remedies Pvt. Ltd (India)

Detailed Segmentation


By Drug

  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Paromomycin
  • Streptomycin
  • Kanamycin

By Mode of administration

  • Feed
  • Injectable
  • Intra-mammary
  • Topical
  • Oral

 By Application

  • Veterinary
  • Skin
  • Respiratory
  • UTI & Pelvic Disease
  • Neonatal Sepsis

By Distribution channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others



  • North America
    • U.S
  • Canada
  • Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America
  • Middle East and Africa (MEA)
  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

For more information:

Like it? Share it!


About the Author

Joined: July 26th, 2019
Articles Posted: 219

More by this author